PAR
Click for more information
0.00% 29.5¢ paradigm biopharmaceuticals limited..

Ann: 2023 Annual Report and Appendix 4E, page-10

  1. PZ99
    280 Posts.
    lightbulb Created with Sketch. 107
    clock Created with Sketch.
    25/08/23
    17:35
    Post #: 69555608
    I’m happy to be corrected, but as I understand it Cartrophen is pretty much identical to what we have, although not approved for human use. I doubt therefore that they’ll be any revenue at all from treating pooches.
    PAR Price at posting: 71.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $103.1M
Open High Low Value Volume
30.0¢ 30.0¢ 29.5¢ $12.33K 41.14K

Buyers (Bids)

No. Vol. Price($)
6 74711 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 18865 6
View Market Depth
Last trade - 13.08pm 22/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.